1/3
Export Ready

Altanib Nova Imatinib 400mg Tablets

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

melizza lifescience

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Verified Seller
Product details

What are the specifications of this product?

Overview

Product Name: Altanib Nova 400mg Tablet Generic Name: Imatinib Mesylate (400mg) Manufacturer: (Usually produced by various oncology-focused companies; “Altanib Nova” is a branded generic) Therapeutic Category:Oncology / Targeted Therapy (Tyrosine Kinase Inhibitor) Product Description: Altanib Nova 400mg Tablet contains Imatinib Mesylate, a targeted anti-cancer medicine belonging to the class of tyrosine kinase inhibitors (TKIs). It works by blocking abnormal proteins that signal cancer cells to multiply, thereby slowing or stopping cancer progression. It is considered a revolutionary therapy for certain types of blood cancers and gastrointestinal tumors. Indications: • Chronic Myeloid Leukemia (CML) – newly diagnosed, chronic phase, accelerated phase, or blast crisis • Acute Lymphoblastic Leukemia (ALL) (Philadelphia chromosome-positive) • Gastrointestinal Stromal Tumors (GISTs) • Myelodysplastic/Myeloproliferative Diseases (MDS/MPD) • Hypereosinophilic Syndrome (HES) & Chronic Eosinophilic Leukemia (CEL) • Dermatofibrosarcoma Protuberans (DFSP)

Product Description

Mechanism of Action:

Imatinib selectively inhibits BCR-ABL tyrosine kinase, the abnormal protein produced by the Philadelphia chromosome in CML, and also inhibits other oncogenic kinases (such as c-KIT and PDGFR).

This prevents cancer cell proliferation and induces apoptosis (programmed cell death).


Dosage & Administration:

• Usual dose: 400mg to 600mg once daily, or as prescribed.

• For GIST or advanced CML, higher doses may be required.

• To be taken with food and a large glass of water to reduce GI irritation.


Key Benefits:

• First-line therapy for CML and GIST.

• Improves survival rates significantly in leukemia patients.

• Oral administration (convenient for patients).


Packaging:

• Bottle/Blister pack of 30 or 60 tablets (400mg each).


Storage:

• Store below 30°C.

• Protect from moisture and light.

• Keep out of reach of children.


Important Notes:

• For use under strict medical supervision only.

• Regular monitoring of blood counts, liver function, and renal function is required.

• Not recommended during pregnancy or breastfeeding.

• Patients may experience side effects such as edema, nausea, muscle cramps, or rash.


ONCOLOGY EXPORTERS FROM INDIA

Oncology byulk exporter from India

Oncology products supplier exporters

Exporters of pharmaceutical products

Melizza Lifescience

Description provided by melizza lifescience.

Specifications

Chemical Name Imatinib Mesylate
Molecular Weight 589.7 g/mol
Mechanism of Action Selective inhibition of BCR-ABL, c-KIT, and PDGFR tyrosine kinases
Pharmacological Class Targeted anti-cancer agent
Typical Dosage 400mg to 600mg once daily or as prescribed
Administration Route Oral
Indications Specificity Targets diseases characterized by tyrosine kinase gene mutations or activation
Storage Requirements Store below 30°C; keep away from moisture and light
Packaging Details Available in 30 or 60 tablet bottles or blisters
Monitoring Requirements Regular blood counts, liver and kidney function tests

Use cases

Category Pharmaceuticals > Oncology > Targeted Cancer Therapies > Tyrosine Kinase Inhibitors
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Altanib Nova Imatinib 400mg Tablets. Answers compiled from verified sellers' commercial terms and platform data.

Q: What makes Altanib Nova 400mg Tablet suitable for treating both blood cancers and gastrointestinal tumors?
A: Altanib Nova 400mg contains Imatinib Mesylate, which selectively inhibits specific tyrosine kinase enzymes such as BCR-ABL, c-KIT, and PDGFR. These kinases are involved in the abnormal growth signaling pathways of both hematologic malignancies like CML and solid tumors such as Gastrointestinal Stromal Tumors (GIST), making this drug effective across these cancer types.
Q: How should the dosage of Altanib Nova 400mg Tablet be adjusted for different cancer phases or types?
A: Typically, the dose ranges from 400mg once daily for newly diagnosed chronic phase CML to up to 600mg or more for advanced phases or GIST. The prescribing oncologist determines the exact dosage based on disease severity, patient tolerance, and response during treatment.
Q: What are the key considerations for storage and handling of Altanib Nova 400mg Tablets to maintain efficacy?
A: The tablets must be stored below 30°C, protected from moisture and direct light exposure. Proper storage in original packaging like blister packs or sealed bottles preserves the chemical stability and therapeutic properties of Imatinib.
Q: Are there any special monitoring protocols required during treatment with Altanib Nova 400mg Tablet?
A: Yes, patients undergoing treatment must have regular monitoring of blood counts, liver function tests, and renal parameters due to possible side effects like edema, hepatic abnormalities, or renal impairment. This ensures the safe administration of the drug.
Q: Can Altanib Nova 400mg Tablets be administered without food?
A: It is recommended to take the tablet with food and a large glass of water to minimize gastrointestinal irritation and maximize absorption.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category
View all →
remtrex 2.5mg, 15mg,
remtrex 2.5mg, 15mg,
Price on request MOQ 1 Centimetre
View Product
erlocip 150mg
erlocip 150mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
lucrin depot 3.75 mg / 11.25 mg injection
lucrin depot 3.75 mg / 11.25 mg injection
Price on request MOQ 1 Centimetre
View Product
truvada-tablets
truvada-tablets
Price on request MOQ 1 Centimetre
View Product
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
Price on request MOQ 1 Piece
View Product
capeta nova 500mg
capeta nova 500mg
Price on request MOQ 1 Centimetre
View Product
Altanib Nova Imatinib 400mg Tablets
Altanib Nova Imatinib 400mg Tablets
Price on request · MOQ 1Centimetre